The Lancet Oncology#health
[Comment] Beyond visual tumour-infiltrating lymphocytes assessmenttranslating…
Factuality: 72/100UnknownLancet Publishing
Stromal tumour-infiltrating lymphocytes (sTILs) have become one of the most clinically informative immune biomarkers in breast cancer,1 associated with improved response to systemic therapy and favourable long-term outcomes.2,3 Reproducibility is not the obstacle to their use…